Last updated: 11/07/2018 14:03:42
A Randomized, Double-Blind, Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Phobia
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A Randomized, Double-Blind, Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Phobia
Trial description: A Randomized, Double-Blind, Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Phobia
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Effectiveness of paroxetine in the treatment of generalized social phobia. Pitts, Cornelius D MD, Oakes, Rosemary MD, and Gergel, Ivan P MD American College of Neuropsychopharmacology 35th Annual Meeting 12/9/1996 San Juan; Puerto Rico
Efficacy of paroxetine in the treatment of patient disability in social phobia. M. Stein, C. D. pitts R. Oakes. Gerge 10th Annual Congress of the European College of Neuropsychopharmacology (ECNP) 9/13/1997 Vienna; Austria
Predictors of response to pharmacotherapy in social anxiety disorder: an analysis of three placebo-controlled paroxetine trials. Stein, D J MD Stein M B MD Lydiard R B MD Pitts C D RPH Oakes R PHE Hunter B MD American Psychiatric Association 152nd Annual Meeting 5/15/1999 Washington, DC; USA
Significant improvement in symptoms of social phobia after paroxetine treatment. Gergel, I, Pitts, C, Oakes, R, and Kumar, R 6th World Congress of Biological Psychiatry 6/22/1997 Nice; France
Stein MB et al. Paroxetine treatment of generalized social phobia (social anxiety disorder) - A randomized controlled trial; JAMA 1998; 280:708-713.
Medical condition
Social Phobia
Product
paroxetine
Collaborators
Not applicable
Study date(s)
April 1995 to February 1996
Type
Not applicable
Phase
4
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1996-28-02
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website